Assessing patient satisfaction with desloratadine after conversion from loratadine, fexofenadine, or cetirizine.
A number of prescription and nonprescription nonsedating antihistamines are available for the treatment of allergic rhinitis. From a managed care perspective, determining the extent to which a medication conversion to desloratadine from loratadine, fexofenadine, or cetirizine results in maintained or increased patient satisfaction with allergy care would be informative for formulary decision makers and other budget holders. To that end, a survey was undertaken of patient medication assessments after a switch in antihistamines. On average, patients who converted to desloratadine from loratadine, fexofenadine, or cetirizine reported increased satisfaction with desloratadine treatment.
Glass
Daniel
D
Harris Interactive Healthcare Division, New York City, New York 10003, USA. dglass@harrisinteractive.com
Harper
Anne
A
D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D017332:Cetirizine / Q000627:therapeutic use*; D002755:Choice Behavior; D003625:Data Collection; D006801:Humans; D017336:Loratadine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008329:Managed Care Programs; D004366:Nonprescription Drugs; D017060:Patient Satisfaction; D016593:Terfenadine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014481:United States
D018926:Anti-Allergic Agents; D004366:Nonprescription Drugs; D017336:Loratadine; D016593:Terfenadine; C093230:fexofenadine; C121345:desloratadine; D017332:Cetirizine